Sanofi has teamed up with Innate Pharma SA in an effort to develop cancer treatments using the body’s own immune system.
The two French companies will develop up to two treatments using antibodies to engage so-called natural-killer cells to attack tumors, according to a statement Sunday. Innate Pharma surged as much as 12 percent to 14.25 euros in Paris. Sanofi showed little change, trading at 74.65 euros.
